Linda Fabiani MSP has tabled a Scottish Parliament motion to congratulate East Kilbride life sciences firm Controlled Therapeutics (Scotland) Ltd (CTS Ltd) on winning the prestigious Queen’s Award for Enterprise in the International Trade category for its obstetric product Propess/Cervidil, the leading brand for the induction of labour in Europe and the USA. This is the second time that the company has received a Queen’s Award for Enterprise.
As well as manufacturing Propess/Cervidil, CTS is involved in the research and development of other clinical products to promote women’s reproductive health. The company has formed a partnership with the international not-for-profit HIV/AIDS prevention agency, CONRAD, to develop drug delivery technology that could help women protect themselves against HIV prevention.
CTS will receive a visit from the Princess Royal Princess Anne at its East Kilbride premises on Monday 6 September.
Linda Fabiani recently joined CTS management and staff at a celebration arranged at the company’s headquarters to thank staff for the contribution they have made to the firm’s success. She said:
“Every time I have been to visit CTS, I have been hugely impressed by the expertise and dedication of everyone there. Staff and management want to build and grow the company’s success, but they are committed first and foremost to developing clinical technology that will improve women’s healthcare.
“CTS are an exemplar of the kind of success that’s being achieved across Scotland’s life sciences sector. It’s great to know that East Kilbride is home to a business that’s leading the way in innovation and helping to improve women’s lives across the world.”